Relapsing-remitting multiple sclerosis (MS) is a disease that affects the central nervous system. The autoimmune disease is associated with symptoms that range from body weakness accompanied with chronic pain to motor and speech difficulties. The signs keep on changing; in early stages, the symptoms can be mild or no symptoms at all and in some cases symptoms flare-up can be seen. Later, MS transforms into a progressive form.
In a bid to find a more effective treatment for MS, researchers in the NIAID-funded Immune Tolerance Network (ITN) carried out clinical trials dubbed HALT-MS, which revealed that administering high-dose immunosuppressive therapy then afterward transplant the patient’s own blood-forming stem cells, has a great potential of inducing sustained remission of relapsing-remitting multiple sclerosis (MS).
The results of the HALT-MS trial that was sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) showed that 69% of those subjected to high-dose immunosuppressive therapy and autologous hematopoietic cell transplant did not show any signs of neither relapse of MS symptoms nor new brain lesions or progression of disability. This is one of the most successful clinical trials after past trials on MS drugs yielded dismal results.
Dr. Shiva Gopal Vasishta is a renowned Neurologist based in Voorhees, New Jersey. He possess over four decades experience in Neurology. Dr. Shiva Gopal Vasishta attended Government Medical College for his medical degree and conducted residency at the Boston City Hospital. Dr. Shiva also has extensive knowledge and expertise in Psychiatry.
Currently, Dr. Shiva Gopal Vasishta is stationed at Eastern Neurodiagnostic Associates and is an affiliate of Kennedy University Hospital. He accepts different insurance plans, which enables him to handle a wide pool of patients. Dr. Gopal Vasishta is duly registered with Neurology board. Apart from his fluency in English, he also speaks other languages such as Spanish.